...
首页> 外文期刊>Polymers for advanced technologies >Preparation of albumin-PAA nanocapsules and their controlled release behavior for drugs
【24h】

Preparation of albumin-PAA nanocapsules and their controlled release behavior for drugs

机译:白蛋白-PAA纳米胶囊的制备及其药物的控释性能

获取原文
获取原文并翻译 | 示例
           

摘要

New kinds of narrowly distributed protein-based nanoparticles, bovine serum albumin-Poly (acrylic acid) (BSA/PAA) nanospheres, and nanocapsules were prepared via in situ polymerization, swelling, and re-aggregation. The structure and morphology of the nanospheres were characterized by UV-Vis, FT-IR, DLS, and TEM. The stability of the BSA/PAA nanospheres and nanocapsules was increased when their skeletons were fixed by cross-linked agents. The nanospheres carried a positive charge and their size was about 80-110 nm. The protein-based nanocapsules were stimuli-responsive with pH value and their hydrodynamic diameter varied from 70 to 230 nm with changes of pH. In vitro release experiments of Rhodamine B and Doxorubicin hydrochloride showed that these biopolymer nanoparticles provided a controlled release of the entrapped drugs for 300 hr.
机译:通过原位聚合,溶胀和重新聚集制备了新型的窄分布的蛋白质基纳米颗粒,牛血清白蛋白-聚(丙烯酸)(BSA / PAA)纳米球和纳米胶囊。纳米球的结构和形态通过紫外-可见,FT-IR,DLS和TEM表征。当BSA / PAA纳米球和纳米胶囊的骨架通过交联剂固定时,其稳定性得到提高。纳米球带有正电荷,其大小约为80-110 nm。基于蛋白质的纳米胶囊对pH值具有刺激反应,并且随着pH的变化,其流体动力学直径在70到230 nm之间变化。罗丹明B和盐酸阿霉素的体外释放实验表明,这些生物聚合物纳米颗粒可在300个小时内控制包埋药物的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号